<!DOCTYPE html>
<html lang="en-US">
<head>
  <meta http-equiv="content-type" content="text/html; charset=UTF-8" />
  <meta name="generator" content="Madoko, version 1.2.3" />
  <meta name="viewport" content="initial-scale=1.0" />
  <meta name="author" content="Dr. Jagdish Varma" />
  <title>Approach to the psycho-oncology patient</title>
  <style type="text/css"  class="link">
  /*# sourceURL=madoko.css */
  
  .madoko .toc>.tocblock .tocblock .tocblock {
    margin-left: 2.25em;
  }
  .madoko .toc>.tocblock .tocblock {
    margin-left: 1.5em;
  }
  .madoko .toc-contents>.tocblock>.tocitem {
    font-weight: bold;
  }
  .madoko .toc {
    margin-top: 1em;
  }
  .madoko p.para-continue {
    margin-bottom: 0pt;
  }
  .madoko .para-block+p {
    margin-top: 0pt;
  }
  .madoko ul.para-block, .madoko ol.para-block {
    margin-top: 0pt;
    margin-bottom: 0pt;
  }
  .madoko ul.para-end, .madoko ol.para-end {
    margin-bottom: 1em;
  }
  .madoko dl {
    margin-left: 0em;
  }
  .madoko blockquote {
    font-style: italic;
  }
  .madoko a.localref {
    text-decoration: none;
  }
  .madoko a.localref:hover {
    text-decoration: underline;
  }
  .madoko .footnotes {
    font-size: smaller;
    margin-top: 2em;
  }
  .madoko .footnotes hr {
    width: 50%;
    text-align: left;
  }
  .madoko .footnote {
    margin-left: 1em;
  }
  .madoko .footnote-before {
    margin-left: -1em;
    width: 1em;
    display: inline-block;
  }
  .madoko .align-center, .madoko .align-center>p {
    text-align: center !important;
  }
  .madoko .align-center pre {
    text-align: left;
  }
  .madoko .align-center>* {
    margin-left: auto !important;
    margin-right: auto !important;
  }
  .madoko .align-left, .madoko .align-left>p {
    text-align: left !important;
  }
  .madoko .align-left>* {
    margin-left: 0pt !important;
    margin-right: auto !important;
  }
  .madoko .align-right, .madoko .align-right>p {
    text-align: right !important;
  }
  .madoko .align-right>* {
    margin-left: auto !important;
    margin-right: 0pt !important;
  }
  .madoko .align-center>table,
  .madoko .align-left>table,
  .madoko .align-right>table {
    text-align: left !important;
  }
  .madoko .equation-before {
    float: right;
  }
  .madoko .bibitem {
    font-size: smaller;
  }
  .madoko .bibsearch {
    font-size: x-small;
    text-decoration:none;
    color: black;
    font-family: "Segoe UI Symbol", Symbola, serif;
  }
  .madoko .block, .madoko .figure, .madoko .bibitem, .madoko .equation, .madoko div.math {
    margin-top: 1ex;
    margin-bottom: 1ex;
  }
  .madoko .figure {
    padding: 0.5em;
    margin-left: 0pt;
    margin-right: 0pt;
  }
  .madoko .hidden {
    display: none;
  }
  .madoko .invisible {
    visibility: hidden;
  }
  .madoko.preview .invisible {
    visibility: visible;
    opacity: 0.5;
  }
  .madoko code.code, .madoko span.code {
    white-space: pre-wrap;
  }
  .madoko hr, hr.madoko {
    border: none;
    border-bottom: black solid 1px;
    margin-bottom: 0.5ex;
  }
  .madoko .framed>*:first-child {
    margin-top: 0pt;
  }
  .madoko .framed>*:last-child {
    margin-bottom: 0pt;
  }
  .madoko ul.list-style-type-dash {
      list-style-type: none !important;
  }
  .madoko ul.list-style-type-dash > li:before {
      content: "\2013";
      position: absolute;
      margin-left: -1em;
  }
  .madoko table.madoko {
    border-collapse: collapse;
  }
  .madoko td, .madoko th {
    padding: 0ex 0.5ex;
    margin: 0pt;
    vertical-align: top;
  }
  .madoko .cell-border-left {
    border-left: 1px solid black;
  }
  .madoko .cell-border-right {
    border-right: 1px solid black;
  }
  .madoko thead>tr:first-child>.cell-line,
  .madoko tbody:first-child>tr:first-child>.cell-line {
    border-top: 1px solid black;
    border-bottom: none;
  }
  .madoko .cell-line, .madoko .cell-double-line {
    border-bottom: 1px solid black;
    border-top: none;
  }
  .madoko .cell-double-line {
    border-top: 1px solid black;
    padding-top: 1.5px !important;
  }
  .madoko .input-mathpre .MathJax_Display {
    text-align: left !important;
  }
  .madoko div.input-mathpre {
    text-align: left;
    margin-top: 1.5ex;
    margin-bottom: 1ex;
  }
  .madoko .math-rendering {
    text-align: left;
    white-space: pre;
    color: gray;
  }
  .madoko .mathdisplay {
    text-align: center;
  }
  .madoko span.math-rendering {
    display:inline-block;
    width:8em;
    overflow-x:auto;
    font-size:70%;
  }
  .madoko span.math-rendering::-webkit-scrollbar {
    width:4px;
  }
  .madoko .pretty table {
    border-collapse: collapse;
  }
  .madoko .pretty td {
    padding: 0em;
  }
  .madoko .pretty td.empty {
    min-width: 1.5ex;
  }
  .madoko .pretty td.expander {
    width: 100em;
  }
  body.madoko, .madoko .serif {
    font-family: Cambria,"Times New Roman","Liberation Serif","Times",serif;
  }
  .madoko .sans-serif {
    font-family: "Calibri", "Optima", sans-serif;
  }
  .madoko .symbol {
    font-family: "Segoe UI Symbol", Symbola, serif;
  }
  body.madoko {
    -webkit-text-size-adjust: 100%;       
    text-rendering: optimizeLegibility;
  }
  body.madoko {
    max-width: 88ex; 
    margin: 1em auto;
    padding: 0em 2em;
  }
  body.preview.madoko {
    padding: 0em 1em;
  }
  .madoko p {
    text-align: justify;
  }
  .madoko h1, .madoko h2, .madoko h3, .madoko h4 {
    margin-top: 1.22em;
    margin-bottom: 1ex;
  }
  .madoko h1+p, .madoko h2+p, .madoko h3+p, .madoko h4+p, .madoko h5+p  {
    margin-top: 1ex;
  }
  .madoko h5, .madoko h6 {
    margin-top: 1ex;
    font-size: 1em;
  }
  .madoko h5 {
    margin-bottom: 0.5ex;
  }
  .madoko h5 + p {
    margin-top: 0.5ex;
  }
  .madoko h6 {
    margin-bottom: 0pt;
  }
  .madoko h6 + p {
    margin-top: 0pt;
  }
  .madoko pre, .madoko code, .madoko kbd, .madoko samp, .madoko tt,
  .madoko .monospace, .madoko .token-indent, .madoko .reveal pre, .madoko .reveal code, .madoko .email {
    font-family: Consolas,"Andale Mono WT","Andale Mono",Lucida Console,Monaco,monospace,monospace;
    font-size: 0.85em;
  }
  .madoko pre code, .madoko .token-indent {
    font-size: 0.95em;
  }
  .madoko pre code {
    font-family: inherit !important;
  }
  .madoko ol.linenums li {
    background-color: white;
    list-style-type: decimal;
  }
  .madoko .remote {
    background-color: #F0FFF0;
  }
  .madoko .remote + * {
    margin-top: 0pt;
  }
  @media print {
    body.madoko {
      font-size: 10pt;
    }
    @page {
      margin: 1in 1.5in;
    }
  }
  @media only screen and (max-device-width:1024px) {
    body.madoko {
      padding: 0em 0.5em;
    }
    .madoko li {
      text-align: left;
    }
  }
  
    </style>
  
  </head>
<body class="madoko">

<div class="body madoko" style="line-adjust:0">

<div class="titleblock align-center para-block" data-line="6" style="text-align:center;line-adjust:0">
<div class="titleheader align-center" data-line="6" style="text-align:center;line-adjust:0">
<div class="title para-block" data-line="6" style="font-size:xx-large;font-weight:bold;margin-bottom:0.5ex;line-adjust:0"><span data-line="6"></span>Approach to the psycho-oncology patient</div></div>
<div class="authors align-center" data-line="11" style="text-align:center;width:80%;line-adjust:0"><table class="authorrow columns block" data-line="11" style="margin-top:2ex;width:100%;line-adjust:0">
<tbody><tr><td class="author column" data-line="11" style="text-align:center;line-adjust:0">
<div class="authorname" data-line="11" style="font-size:large;line-adjust:0"><span data-line="11"></span>Dr. Jagdish Varma</div>
<div class="authoraddress" data-line="14" style="line-adjust:0"><span data-line="14"></span>Professor of Psychiatry, Bhaikaka University, Karamsad</div></td></tr></tbody></table></div></div><span data-line="8"></span>
<nav class="toc toc-contents"><h2 id="sec-contents" class="clearnum h1 heading-contents" data-heading-depth="1" style="display:block">Contents</h2>
<div class="tocblock tocblock1">
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-introduction" data-toc-depth="1" data-toc-line="[1]{.heading-label}.&#8194;Introduction" style="toctarget:sec-introduction"><a href="#sec-introduction" class="localref"><span class="heading-label">1</span>.&#8194;Introduction</a></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-evaluation-should-include" data-toc-depth="1" data-toc-line="[2]{.heading-label}.&#8194;Evaluation should include" style="toctarget:sec-evaluation-should-include"><a href="#sec-evaluation-should-include" class="localref"><span class="heading-label">2</span>.&#8194;Evaluation should include</a></div>
<div class="tocblock tocblock2">
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-symptoms-of-depression" data-toc-depth="2" data-toc-line="[2.1]{.heading-label}.&#8194;Symptoms of depression" style="toctarget:sec-symptoms-of-depression"><a href="#sec-symptoms-of-depression" class="localref"><span class="heading-label">2.1</span>.&#8194;Symptoms of depression</a></div>
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-rule-out-syndromic-differentials" data-toc-depth="2" data-toc-line="[2.2]{.heading-label}.&#8194;Rule out syndromic differentials" style="toctarget:sec-rule-out-syndromic-differentials"><a href="#sec-rule-out-syndromic-differentials" class="localref"><span class="heading-label">2.2</span>.&#8194;Rule out syndromic differentials</a></div>
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-look-for-comorbidities" data-toc-depth="2" data-toc-line="[2.3]{.heading-label}.&#8194;Look for comorbidities" style="toctarget:sec-look-for-comorbidities"><a href="#sec-look-for-comorbidities" class="localref"><span class="heading-label">2.3</span>.&#8194;Look for comorbidities</a></div>
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-past-psychiatric-ho" data-toc-depth="2" data-toc-line="[2.4]{.heading-label}.&#8194;Past Psychiatric h/o" style="toctarget:sec-past-psychiatric-ho"><a href="#sec-past-psychiatric-ho" class="localref"><span class="heading-label">2.4</span>.&#8194;Past Psychiatric h/o</a></div>
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-look-for-etiological-factors" data-toc-depth="2" data-toc-line="[2.5]{.heading-label}.&#8194;Look for etiological factors" style="toctarget:sec-look-for-etiological-factors"><a href="#sec-look-for-etiological-factors" class="localref"><span class="heading-label">2.5</span>.&#8194;Look for etiological factors</a></div>
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-risk-assessment" data-toc-depth="2" data-toc-line="[2.6]{.heading-label}.&#8194;Risk assessment" style="toctarget:sec-risk-assessment"><a href="#sec-risk-assessment" class="localref"><span class="heading-label">2.6</span>.&#8194;Risk assessment</a></div></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-common-diagnoses-to-consider" data-toc-depth="1" data-toc-line="[3]{.heading-label}.&#8194;Common diagnoses to consider" style="toctarget:sec-common-diagnoses-to-consider"><a href="#sec-common-diagnoses-to-consider" class="localref"><span class="heading-label">3</span>.&#8194;Common diagnoses to consider</a></div>
<div class="tocblock tocblock2">
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-major-depression" data-toc-depth="2" data-toc-line="[3.1]{.heading-label}.&#8194;Major depression" style="toctarget:sec-major-depression"><a href="#sec-major-depression" class="localref"><span class="heading-label">3.1</span>.&#8194;Major depression</a></div>
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-adjustment-disorder" data-toc-depth="2" data-toc-line="[3.2]{.heading-label}.&#8194;Adjustment disorder" style="toctarget:sec-adjustment-disorder"><a href="#sec-adjustment-disorder" class="localref"><span class="heading-label">3.2</span>.&#8194;Adjustment disorder</a></div>
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-primary-or-secondary-mania" data-toc-depth="2" data-toc-line="[3.3]{.heading-label}.&#8194;Primary or Secondary Mania" style="toctarget:sec-primary-or-secondary-mania"><a href="#sec-primary-or-secondary-mania" class="localref"><span class="heading-label">3.3</span>.&#8194;Primary or Secondary Mania</a></div></div>
<div class="tocitem tocitem1" data-toc-target-elem="h1" data-toc-target="sec-management" data-toc-depth="1" data-toc-line="[4]{.heading-label}.&#8194;Management" style="toctarget:sec-management"><a href="#sec-management" class="localref"><span class="heading-label">4</span>.&#8194;Management</a></div>
<div class="tocblock tocblock2">
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-medication-management" data-toc-depth="2" data-toc-line="[4.1]{.heading-label}.&#8194;Medication management" style="toctarget:sec-medication-management"><a href="#sec-medication-management" class="localref"><span class="heading-label">4.1</span>.&#8194;Medication management</a></div>
<div class="tocblock tocblock3">
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-antidepressants" data-toc-depth="3" data-toc-line="[4.1.1]{.heading-label}.&#8194;Antidepressants" style="toctarget:sec-antidepressants"><a href="#sec-antidepressants" class="localref"><span class="heading-label">4.1.1</span>.&#8194;Antidepressants</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-psychostimulants" data-toc-depth="3" data-toc-line="[4.1.2]{.heading-label}.&#8194;Psychostimulants" style="toctarget:sec-psychostimulants"><a href="#sec-psychostimulants" class="localref"><span class="heading-label">4.1.2</span>.&#8194;Psychostimulants</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-mood-stabilizers-and-antipsychotics" data-toc-depth="3" data-toc-line="[4.1.3]{.heading-label}.&#8194;Mood Stabilizers and Antipsychotics" style="toctarget:sec-mood-stabilizers-and-antipsychotics"><a href="#sec-mood-stabilizers-and-antipsychotics" class="localref"><span class="heading-label">4.1.3</span>.&#8194;Mood Stabilizers and Antipsychotics</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-generic-comment-on-medications" data-toc-depth="3" data-toc-line="[4.1.4]{.heading-label}.&#8194;Generic comment on medications" style="toctarget:sec-generic-comment-on-medications"><a href="#sec-generic-comment-on-medications" class="localref"><span class="heading-label">4.1.4</span>.&#8194;Generic comment on medications</a></div></div>
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-management-of-suicide-threat" data-toc-depth="2" data-toc-line="[4.2]{.heading-label}.&#8194;Management of Suicide threat" style="toctarget:sec-management-of-suicide-threat"><a href="#sec-management-of-suicide-threat" class="localref"><span class="heading-label">4.2</span>.&#8194;Management of Suicide threat</a></div>
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-psychotherapy-for-mood-disorders" data-toc-depth="2" data-toc-line="[4.3]{.heading-label}.&#8194;Psychotherapy for Mood Disorders" style="toctarget:sec-psychotherapy-for-mood-disorders"><a href="#sec-psychotherapy-for-mood-disorders" class="localref"><span class="heading-label">4.3</span>.&#8194;Psychotherapy for Mood Disorders</a></div>
<div class="tocitem tocitem2" data-toc-target-elem="h2" data-toc-target="sec-other-non-pharmacological-intreventions" data-toc-depth="2" data-toc-line="[4.4]{.heading-label}.&#8194;Other non-pharmacological intreventions" style="toctarget:sec-other-non-pharmacological-intreventions"><a href="#sec-other-non-pharmacological-intreventions" class="localref"><span class="heading-label">4.4</span>.&#8194;Other non-pharmacological intreventions</a></div>
<div class="tocblock tocblock3">
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-spiritual-inteventions---fica-assessment" data-toc-depth="3" data-toc-line="[4.4.1]{.heading-label}.&#8194;Spiritual inteventions - FICA assessment" style="toctarget:sec-spiritual-inteventions---fica-assessment"><a href="#sec-spiritual-inteventions---fica-assessment" class="localref"><span class="heading-label">4.4.1</span>.&#8194;Spiritual inteventions - FICA assessment</a></div>
<div class="tocitem tocitem3" data-toc-target-elem="h3" data-toc-target="sec-meditation" data-toc-depth="3" data-toc-line="[4.4.2]{.heading-label}.&#8194;Meditation" style="toctarget:sec-meditation"><a href="#sec-meditation" class="localref"><span class="heading-label">4.4.2</span>.&#8194;Meditation</a></div></div></div></div></nav><h2 id="sec-introduction" class="h1" data-line="10" data-heading-depth="1" style="display:block"><span data-line="10"></span><span class="heading-before"><span class="heading-label">1</span>.&#8194;</span><span data-line="10"></span>Introduction</h2>
<p class="p noindent" data-line="12"><span data-line="12"></span>Patients should be assessed when they or their families complain of depressive symptoms and when a mood disorder is suspected clinically.
</p>
<p class="p indent" data-line="14"><span data-line="14"></span>Rating scales are routinely used to <span data-line="14"></span><strong class="strong-star2">screen for mood disorders.</strong><span data-line="14"></span> Patient Health Questionnaire (PHQ-9) is a popular tool with 93% sensitivity and 81% specificity. It on its own is not sufficient for diagnosis.
</p>
<p class="p indent" data-line="16"><span data-line="16"></span>Currently one to one interview will be done with those who <span data-line="16"></span><strong class="strong-star2">score more than 15 on PHQ-9 (LR of MDE 7) or scoring 1 or more on question 9 of PHQ-9</strong><span data-line="16"></span> (suicidal ideation)
</p><h2 id="sec-evaluation-should-include" class="h1" data-line="18" data-heading-depth="1" style="display:block"><span data-line="18"></span><span class="heading-before"><span class="heading-label">2</span>.&#8194;</span><span data-line="18"></span>Evaluation should include</h2><h3 id="sec-symptoms-of-depression" class="h2" data-line="19" data-heading-depth="2" style="display:block"><span data-line="19"></span><span class="heading-before"><span class="heading-label">2.1</span>.&#8194;</span><span data-line="19"></span>Symptoms of depression</h3>
<p class="p noindent" data-line="20"><span data-line="20"></span>More emphasis must be placed on psychological symptoms
<span data-line="21"></span> <span data-line="21"></span> <span data-line="21"></span>- dysphoria
<span data-line="22"></span> <span data-line="22"></span> <span data-line="22"></span>- anhedonia
<span data-line="23"></span> <span data-line="23"></span> <span data-line="23"></span>- hopelessness
<span data-line="24"></span> <span data-line="24"></span> <span data-line="24"></span>- feelings of guilt
</p>
<p class="p indent" data-line="26"><span data-line="26"></span>Because vegetative and somatic symptoms are common to the experience of cancer and it<span data-line="26"></span>&#39;<span data-line="26"></span>s treatment as well as depression
</p><h3 id="sec-rule-out-syndromic-differentials" class="h2" data-line="28" data-heading-depth="2" style="display:block"><span data-line="28"></span><span class="heading-before"><span class="heading-label">2.2</span>.&#8194;</span><span data-line="28"></span>Rule out syndromic differentials</h3>
<p class="p noindent" data-line="29"><span data-line="29"></span>Hypoactive delirium, Cognitive impairment<span data-line="29"></span> <span data-line="29"></span>- can be comorbid with depression
</p><h3 id="sec-look-for-comorbidities" class="h2" data-line="31" data-heading-depth="2" style="display:block"><span data-line="31"></span><span class="heading-before"><span class="heading-label">2.3</span>.&#8194;</span><span data-line="31"></span>Look for comorbidities</h3>
<p class="p noindent" data-line="32"><span data-line="32"></span>Anxiety, psychosis, mania, cognitive impairments, substance use
</p><h3 id="sec-past-psychiatric-ho" class="h2" data-line="34" data-heading-depth="2" style="display:block"><span data-line="34"></span><span class="heading-before"><span class="heading-label">2.4</span>.&#8194;</span><span data-line="34"></span>Past Psychiatric h/o</h3>
<p class="p noindent" data-line="35"><span data-line="35"></span>Depression and suicidal attempts
</p><h3 id="sec-look-for-etiological-factors" class="h2" data-line="37" data-heading-depth="2" style="display:block"><span data-line="37"></span><span class="heading-before"><span class="heading-label">2.5</span>.&#8194;</span><span data-line="37"></span>Look for etiological factors</h3>
<p class="p noindent" data-line="38"><span data-line="38"></span><strong class="strong-star2">Drugs</strong><span data-line="38"></span> <span data-line="38"></span>- corticosteroids, especially in chronic use, may cause depressive syndromes and acutely may cause presentations consistent with mania.
</p>
<p class="p indent" data-line="40"><span data-line="40"></span><strong class="strong-star2">Central nervous system depressant medications</strong><span data-line="40"></span>, including opioid analgesics, benzodiazepines, and barbiturates, may cause depression in patients with idiosyncratic vulnerability or with cognitive impairments.
</p>
<p class="p indent" data-line="42"><span data-line="42"></span><strong class="strong-star2">Anti-neoplastic drugs</strong><span data-line="42"></span> <span data-line="42"></span>- Depressive syndromes may be encountered as side effects of vinca alkyloids; L-asparaginase; procarbazine; of much greater concern are biological response modifiers including interferon-alpha and interleukin-2 (IL-2). Interferon especially is associated with depression and may occasionally cause mania.
</p>
<p class="p indent" data-line="44"><span data-line="44"></span><strong class="strong-star2">Unrelieved pain</strong><span data-line="44"></span> <span data-line="44"></span>- is a significant cause of depression in cancer patients. Rate pain on a scale of 0-10.
</p>
<p class="p indent" data-line="46"><span data-line="46"></span><strong class="strong-star2">Social support</strong><span data-line="46"></span> <span data-line="46"></span>- level of social support and social isolation to be assessed
</p><h3 id="sec-risk-assessment" class="h2" data-line="48" data-heading-depth="2" style="display:block"><span data-line="48"></span><span class="heading-before"><span class="heading-label">2.6</span>.&#8194;</span><span data-line="48"></span>Risk assessment</h3>
<p class="p noindent" data-line="49"><span data-line="49"></span><strong class="strong-star2">Suicidal ideations</strong><span data-line="49"></span> (it is fairly common for cancer patients to have passive suicidal ideations with no active desire to die, or plan.)
</p>
<p class="p indent" data-line="51"><span data-line="51"></span>Most of the generic risk factors for suicide (SADPERSONS) are already covered in the protocol above. Specific cancer related risks are advanced disease and unrelieved pain.
</p>
<p class="p indent" data-line="53"><span data-line="53"></span>Conducted in an open, nonjudgmental manner, gives the patient permission  to talk about thoughts that may be very frightening.
</p>
<p class="p indent" data-line="55"><span data-line="55"></span>Slightly indirect approach to the question of suicide risk may be helpful at first. The patient might be asked if he ever has thoughts that life is no longer worth living; if yes, does he have thoughts of ending his own life and if so, does he have a plan?
</p><h2 id="sec-common-diagnoses-to-consider" class="h1" data-line="57" data-heading-depth="1" style="display:block"><span data-line="57"></span><span class="heading-before"><span class="heading-label">3</span>.&#8194;</span><span data-line="57"></span>Common diagnoses to consider</h2><h3 id="sec-major-depression" class="h2" data-line="58" data-heading-depth="2" style="display:block"><span data-line="58"></span><span class="heading-before"><span class="heading-label">3.1</span>.&#8194;</span><span data-line="58"></span>Major depression</h3>
<p class="p noindent" data-line="59"><span data-line="59"></span>Diagnosis of primary or secondary major depression will experience one or both of the hallmark emotional symptoms of depression (dysphoria, anhedonia) and at least five of the listed symptoms. DSM-5 criteria also require the presence of vegetative and/or somatic symptoms, which, with psychological symptoms, must be present for at least two weeks and represent a distinct change from prior function
</p><h3 id="sec-adjustment-disorder" class="h2" data-line="61" data-heading-depth="2" style="display:block"><span data-line="61"></span><span class="heading-before"><span class="heading-label">3.2</span>.&#8194;</span><span data-line="61"></span>Adjustment disorder</h3>
<p class="p noindent" data-line="62"><span data-line="62"></span>Adjustment disorders (also known as “minor depression” or “reactive depression”) are the most common mood disorders diagnosed in cancer patients. The diagnosis requires that the patient experiences sadness or inability to take pleasure in life as a response to a stressor like cancer temporally related to the onset of symptoms, and that the symptoms are sufficiently severe that they cause impairment of social or occupational function. They may not meet criteria for major depression or secondary mood disorders because low mood is not persistent.
</p><h3 id="sec-primary-or-secondary-mania" class="h2" data-line="64" data-heading-depth="2" style="display:block"><span data-line="64"></span><span class="heading-before"><span class="heading-label">3.3</span>.&#8194;</span><span data-line="64"></span>Primary or Secondary Mania</h3>
<p class="p noindent" data-line="65"><span data-line="65"></span>Elevated and expansive or irritable mood and rapid or pressured speech. Thought processes can seem illogical. Patients often experience a decreased need for sleep, increased energy and impulsive or erratic behavior. Patients may speak of depressed mood when they are irritable.
</p><h2 id="sec-management" class="h1" data-line="67" data-heading-depth="1" style="display:block"><span data-line="67"></span><span class="heading-before"><span class="heading-label">4</span>.&#8194;</span><span data-line="67"></span>Management</h2><h3 id="sec-medication-management" class="h2" data-line="68" data-heading-depth="2" style="display:block"><span data-line="68"></span><span class="heading-before"><span class="heading-label">4.1</span>.&#8194;</span><span data-line="68"></span>Medication management</h3><h4 id="sec-antidepressants" class="h3" data-line="69" data-heading-depth="3" style="display:block"><span data-line="69"></span><span class="heading-before"><span class="heading-label">4.1.1</span>.&#8194;</span><span data-line="69"></span>Antidepressants</h4>
<ul class="ul list-dash compact" data-line="70">
<li class="li ul-li list-dash-li compact-li" data-line="70"><span data-line="70"></span>Use of antidepressants is a matter or clinical judgement
</li>
<li class="li ul-li list-dash-li compact-li" data-line="71"><span data-line="71"></span>Patients who meet criteria for major depression should be treated.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="72"><span data-line="72"></span>Patients with severe adjustment disorders or who do not meet full criteria for depression may also benefit from antidepressant therapy.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="73"><span data-line="73"></span>Almost all the antidepressants available in general clinical practice can be used in cancer patients.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="74"><span data-line="74"></span>Selective serotonin reuptake inhibitor (SSRI) antidepressants (citalopram, fluoxetine, escitalopram, paroxetine, sertraline) and the newer combination agents
(bupropion, duloxetine, venlafaxine, mirtazapine) are used most frequently in oncology because of their safety and generally favorable side effect profiles.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="76"><span data-line="76"></span>Tricyclic antidepressants (TCAs) are potentially problematic because of anticholinergic and anti-alpha-adrenergic effects. However, they are inexpensive and can be useful in patients with co-morbid neuropathic pain syndromes.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="77"><span data-line="77"></span>They take anywhere from 2–4 weeks to take effect.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="78"><span data-line="78"></span>Patients should be monitored for side effects and response of symptoms.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="79"><span data-line="79"></span>Seriously ill and elderly patients should be started at low doses, with cautious dose escalation if the drug is tolerated.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="80"><span data-line="80"></span>Continue for 4–6 months of sustained response before considering discontinuation.
</li></ul>
<h4 id="sec-psychostimulants" class="h3" data-line="82" data-heading-depth="3" style="display:block"><span data-line="82"></span><span class="heading-before"><span class="heading-label">4.1.2</span>.&#8194;</span><span data-line="82"></span>Psychostimulants</h4>
<ul class="ul list-dash compact" data-line="83">
<li class="li ul-li list-dash-li compact-li" data-line="83"><span data-line="83"></span>modafinil
</li>
<li class="li ul-li list-dash-li compact-li" data-line="84"><span data-line="84"></span>methylphenidate.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="85"><span data-line="85"></span>Can be very beneficial in treatment of associated fatigue, mild cognitive impairment, and anorexia, especially in advanced and end-stage disease settings.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="86"><span data-line="86"></span>More rapid effect than standard antidepressants
</li>
<li class="li ul-li list-dash-li compact-li" data-line="87"><span data-line="87"></span>Generally well tolerated but can have adverse effects on blood pressure
</li></ul>
<h4 id="sec-mood-stabilizers-and-antipsychotics" class="h3" data-line="89" data-heading-depth="3" style="display:block"><span data-line="89"></span><span class="heading-before"><span class="heading-label">4.1.3</span>.&#8194;</span><span data-line="89"></span>Mood Stabilizers and Antipsychotics</h4>
<ul class="ul list-dash compact" data-line="90">
<li class="li ul-li list-dash-li compact-li" data-line="90"><span data-line="90"></span>Cancer patients with preexisting bipolar mood disorder ideally should be maintained on mood stabilizers (i.e., lithium, valproic acid) and antipsychotic medications.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="91"><span data-line="91"></span>Dehydration associated with treatment-associated vomiting and diarrhea can affect lithium levels, which should be monitored closely during active treatment.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="92"><span data-line="92"></span>Steroid-induced mania will usually respond to decrease of steroid doses.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="93"><span data-line="93"></span>In some cases this is not feasible and the patient will require treatment with an antipsychotic drug such as olanzapine.
</li></ul>
<h4 id="sec-generic-comment-on-medications" class="h3" data-line="95" data-heading-depth="3" style="display:block"><span data-line="95"></span><span class="heading-before"><span class="heading-label">4.1.4</span>.&#8194;</span><span data-line="95"></span>Generic comment on medications</h4>
<ul class="ul list-dash compact" data-line="96">
<li class="li ul-li list-dash-li compact-li" data-line="96"><span data-line="96"></span>Drug-drug interactions and possible cardiac conduction abnormalities should be monitored.
</li></ul>
<h3 id="sec-management-of-suicide-threat" class="h2" data-line="98" data-heading-depth="2" style="display:block"><span data-line="98"></span><span class="heading-before"><span class="heading-label">4.2</span>.&#8194;</span><span data-line="98"></span>Management of Suicide threat</h3>
<ul class="ul list-dash compact" data-line="99">
<li class="li ul-li list-dash-li compact-li" data-line="99"><span data-line="99"></span>Safety of patients at risk for suicide must be secured.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="100"><span data-line="100"></span>Do not leave alone until they can be evaluated and started in treatment.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="101"><span data-line="101"></span>May need to pursue admission to hospital.
</li>
<li class="li ul-li list-dash-li compact-li" data-line="102"><span data-line="102"></span>Any disease and treatment related factors (especially pain) that may be contributing to the presenting mood disorder should be addressed.
</li></ul>
<h3 id="sec-psychotherapy-for-mood-disorders" class="h2" data-line="104" data-heading-depth="2" style="display:block"><span data-line="104"></span><span class="heading-before"><span class="heading-label">4.3</span>.&#8194;</span><span data-line="104"></span>Psychotherapy for Mood Disorders</h3>
<p class="p noindent" data-line="105"><span data-line="105"></span>Supportive psychotherapy in patients with major and minor depression is almost universally appropriate as one element of treatment.
- Goal: decrease perception of isolation and bolster coping skills.
- Support can be provided by members of the primary team and also by allied health professionals including social workers and chaplains.
- More formal and structured psychotherapy may be appropriate on a case-by-case basis. This usually involves referral to a mental health professional of any discipline with appropriate training.
</p><h3 id="sec-other-non-pharmacological-intreventions" class="h2" data-line="110" data-heading-depth="2" style="display:block"><span data-line="110"></span><span class="heading-before"><span class="heading-label">4.4</span>.&#8194;</span><span data-line="110"></span>Other non-pharmacological intreventions</h3><h4 id="sec-spiritual-inteventions---fica-assessment" class="h3" data-line="111" data-heading-depth="3" style="display:block"><span data-line="111"></span><span class="heading-before"><span class="heading-label">4.4.1</span>.&#8194;</span><span data-line="111"></span>Spiritual inteventions<span data-line="111"></span> <span data-line="111"></span>- FICA assessment</h4>
<p class="p noindent" data-line="112"><span data-line="112"></span>Faith, Importance, Community, Address Questions. Spirituality is an important part of many people’s lives and provides a sense of connectedness and comfort during times of illness and distress. Cancer often precipitates a spiritual crisis as a person searches for meaning in their life and illness. Spirituality is evaluated by questions around four main themes to guide history taking and give a better sense of the patient’s dependence on spirituality in coping with illness. They are not scored and focus on strengths. The four themes—faith, importance, community, address—can be remembered using the acronym, FICA
</p>
<p class="p indent" data-line="114"><span data-line="114"></span>  <span data-line="114"></span><strong class="strong-star2">F</strong><span data-line="114"></span>: What is your faith or belief?
  Do you consider yourself spiritual or religious?
  What things do you believe in that give meaning to your life?
</p>
<p class="p indent" data-line="118"><span data-line="118"></span>  <span data-line="118"></span><strong class="strong-star2">I</strong><span data-line="118"></span>: Is it important in your life?
  What influence does it have on how you take care of yourself?
  How have your beliefs influenced your behavior during this illness?
  What role do your beliefs play in regaining your health?
</p>
<p class="p indent" data-line="123"><span data-line="123"></span>  <span data-line="123"></span><strong class="strong-star2">C</strong><span data-line="123"></span>: Are you part of a spiritual or religious community?
  Is this of support to you and how?
  Is there a person or group of people you really love or who are really important to you?
</p>
<p class="p indent" data-line="127"><span data-line="127"></span>  <span data-line="127"></span><strong class="strong-star2">A</strong><span data-line="127"></span>: How would you like me, your health-care provider, to address these issues in your health care?
</p><h4 id="sec-meditation" class="h3" data-line="129" data-heading-depth="3" style="display:block"><span data-line="129"></span><span class="heading-before"><span class="heading-label">4.4.2</span>.&#8194;</span><span data-line="129"></span>Meditation</h4>
<p class="p noindent" data-line="130"><span data-line="130"></span>  With cancer specific suggestions. Recording of PMR with soothing music and cancer specific suggestions will be shared with pateints or family members for daily practice.
</p><span data-line=""></span></div>
</body>

</html>
